Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e17519
Abstract: e17519Background: The multi-center, randomized, open-lable, phaseâ…¢ trial discussed in the present study was performed to compare clinical outcomes of nedaplatin (NDP) plus paclitaxel, and carboplat... read more here.
Keywords: randomized open; multi center; center randomized; paclitaxel plus ... See more keywords